Polivy - direct healthcare professional communication (DHPC)

polatuzumab vedotin
DHPC Human

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Polivy
Active substance
polatuzumab vedotin
Therapeutic area (MeSH)
Lymphoma, B-Cell
Procedure number
EMEA/H/C/004870
DHPC type
Quality defect
Human ATC codes
L01FX06

Share this page